PolyCore Therapeutics Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $456K
Latest Deal Amount
  • Investors
  • 5

PolyCore Therapeutics General Information

Description

Developer of therapies intended to treat dyskinesia and cognitive impairment associated with central nervous system disorders. The company's research focuses on the development of new, affordable drugs to manage the side effects of treating Parkinson's and other neurological diseases, enabling patients to improve mobility and quality of life, while reducing overall healthcare costs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 3180 Chestnut Street
  • Suite 104
  • Philadelphia, PA 19104-3282
  • United States
+1 (215) 000-0000

PolyCore Therapeutics Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PolyCore Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 17-May-2021 $456K 00000 Completed Generating Revenue
6. Grant 20-Aug-2020 00.00 00000 Completed Generating Revenue
5. Early Stage VC 00000 00000 Completed Generating Revenue
4. Early Stage VC 22-Jun-2016 00000 00000 Completed Generating Revenue
3. Early Stage VC 00000 00000 Completed Startup
2. Grant $332K $25K Completed Startup
1. Accelerator/Incubator $25K $25K Completed Startup
To view PolyCore Therapeutics’s complete valuation and funding history, request access »

PolyCore Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
Kelly Beck Chief Executive Officer & Board Member
Thais Sielecki Ph.D Chief Operating Officer
Sandhya Kortagere Ph.D Co-Founder, Chief Scientific Officer & Board Member
Jim Harris Co-Founder & Chairman
You’re viewing 4 of 6 executive team members. Get the full list »

PolyCore Therapeutics Board Members (5)

Name Representing Role Since
Christopher Cashman Self Board Member 000 0000
Jennifer Hartt Ben Franklin Technology Partner of Southeastern Pennsylvania Board Member 000 0000
Jim Harris PolyCore Therapeutics Co-Founder & Chairman 000 0000
Kelly Beck PolyCore Therapeutics Chief Executive Officer & Board Member 000 0000
Sandhya Kortagere Ph.D PolyCore Therapeutics Co-Founder, Chief Scientific Officer & Board Member 000 0000
To view PolyCore Therapeutics’s complete board members history, request access »

PolyCore Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government Minority 000 0000 000000 0
Ben Franklin Technology Partner of Southeastern Pennsylvania Venture Capital Minority 000 0000 000000 0
Drexel Ventures Venture Capital Minority 000 0000 000000 0
Drexel University Endowment Limited Partner 000 0000 000000 0
Science Center Accelerator/Incubator Minority 000 0000 000000 0
To view PolyCore Therapeutics’s complete investors history, request access »